Literature DB >> 1904558

Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats.

T Niwa1, T Yazawa, M Ise, M Sugano, T Kodama, Y Uehara, K Maeda.   

Abstract

Serum indoxyl sulfate, which is markedly accumulated in uremic patients, cannot be removed efficiently by hemodialysis due to its albumin binding. To determine if oral adsorbent (AST-120) can decrease its serum concentration in uremic state, oral adsorbent was administered to experimental nephrectomized uremic rats. Uremic rats fed with oral adsorbent showed a significantly lower serum concentration of indoxyl sulfate compared to control uremic rats, even when serum concentrations of urea nitrogen and creatinine were not significantly decreased in the uremic rats fed with oral adsorbent. Indoxyl sulfate was detected only at a lower concentration in bile as compared with the serum of uremic rats. These results suggest that oral adsorbent adsorbs indole, a precursor of indoxyl sulfate, in the intestine and prevents the accumulation of indoxyl sulfate in uremic rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904558     DOI: 10.1159/000186222

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  12 in total

1.  Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction.

Authors:  Hideki Fujii; Yuriko Yonekura; Yusuke Yamashita; Keiji Kono; Kentaro Nakai; Shunsuke Goto; Mikio Sugano; Sumie Goto; Ayako Fujieda; Yoshiharu Ito; Shinichi Nishi
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

2.  Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

Authors:  Gerald Schulman; Tomas Berl; Gerald J Beck; Giuseppe Remuzzi; Eberhard Ritz; Kiyoshi Arita; Akira Kato; Miho Shimizu
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

3.  Dihydroartemisinin inhibits indoxyl sulfate (IS)-promoted cell cycle progression in mesangial cells by targeting COX-2/mPGES-1/PGE2 cascade.

Authors:  Harr-Keshauve Mungun; Shuzhen Li; Yue Zhang; Songming Huang; Zhanjun Jia; Guixia Ding; Aihua Zhang
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

Review 4.  Uremic toxin and bone metabolism.

Authors:  Yoshiko Iwasaki; Hideyuki Yamato; Tomoko Nii-Kono; Ayako Fujieda; Motoyuki Uchida; Atsuko Hosokawa; Masaru Motojima; Masafumi Fukagawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

5.  Dialysate with high dissolved hydrogen facilitates dissociation of indoxyl sulfate from albumin.

Authors:  Yoshihiro Tange; Shingo Takesawa; Shigenori Yoshitake
Journal:  Nephrourol Mon       Date:  2015-02-25

6.  Indoxyl Sulfate Induces Mesangial Cell Proliferation via the Induction of COX-2.

Authors:  Shuzhen Li; Sijie Cheng; Zhenzhen Sun; Harr-Keshauve Mungun; Wei Gong; Jing Yu; Weiwei Xia; Yue Zhang; Songming Huang; Aihua Zhang; Zhanjun Jia
Journal:  Mediators Inflamm       Date:  2016-10-23       Impact factor: 4.711

7.  Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.

Authors:  Stanislas Bataille; Marion Pelletier; Marion Sallée; Yvon Berland; Nathalie McKay; Ariane Duval; Stéphanie Gentile; Yosra Mouelhi; Philippe Brunet; Stéphane Burtey
Journal:  BMC Nephrol       Date:  2017-07-26       Impact factor: 2.388

8.  In vitro activity of AST-120 that suppresses indole signaling in Escherichia coli, which attenuates drug tolerance and virulence.

Authors:  Hidetada Hirakawa; Motoyuki Uchida; Kumiko Kurabayashi; Fuyuhiko Nishijima; Ayako Takita; Haruyoshi Tomita
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

9.  Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB.

Authors:  Dilinaer Bolati; Hidehisa Shimizu; Maimaiti Yisireyili; Fuyuhiko Nishijima; Toshimitsu Niwa
Journal:  BMC Nephrol       Date:  2013-03-04       Impact factor: 2.388

10.  The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

Authors:  Gerald Schulman; Tomas Berl; Gerald J Beck; Giuseppe Remuzzi; Eberhard Ritz; Miho Shimizu; Yuko Shobu; Mami Kikuchi
Journal:  BMC Nephrol       Date:  2016-09-30       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.